Profiel
Mahima Datla is currently the Managing Director & Director at Biological E.
Ltd.
and also holds the position of Director at Global Health Innovative Technology Fund.
Actieve functies van Mahima Datla
| Bedrijven | Functie | Begin |
|---|---|---|
Biological E. Ltd.
 Biological E. Ltd. Pharmaceuticals: MajorHealth Technology Biological E. Ltd. operates as a biological products company. It manufactures liver extracts and anti-coagulants. The company was founded by Datla Venkata Krishnam Raju in 1953 and is headquartered in Hyderabad, India. | Algemeen Directeur | - |
Global Health Innovative Technology Fund
 Global Health Innovative Technology Fund Investment ManagersFinance Global Health Innovative Technology Fund provides funding of scientific research and development for anti-infectives and diagnostics for diseases that affect the developing world. Its activities include facilitation of global research and development partnerships for the discovery and development of new health technologies for the developing world, investment in these global research and development partnerships through a grant-making mechanism and advancement of Japan’s contribution to global health. The company is headquartered in Minato-ku, Japan. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Biological E. Ltd.
Biological E. Ltd. Pharmaceuticals: MajorHealth Technology Biological E. Ltd. operates as a biological products company. It manufactures liver extracts and anti-coagulants. The company was founded by Datla Venkata Krishnam Raju in 1953 and is headquartered in Hyderabad, India. | Health Technology |
Global Health Innovative Technology Fund
Global Health Innovative Technology Fund Investment ManagersFinance Global Health Innovative Technology Fund provides funding of scientific research and development for anti-infectives and diagnostics for diseases that affect the developing world. Its activities include facilitation of global research and development partnerships for the discovery and development of new health technologies for the developing world, investment in these global research and development partnerships through a grant-making mechanism and advancement of Japan’s contribution to global health. The company is headquartered in Minato-ku, Japan. | Finance |
